Haemonetics Corp (HAE) shareholders
Close on Nov 17, 2026Market cap $5.50BP/E 59.0Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 6,056,881 | 11.90% | 13G (passive) amendment | Dec 31, 2023 |
| / Neuberger Berman Group LLC Joint filing with / Neuberger Berman Investment Advisers LLC (6.89%) | 3,531,181 | 6.96% | 13G (passive) amendment | Dec 31, 2023 |
| AQR Capital Management, LLC Joint filing with AQR Capital Management Holdings, LLC (6.76%) | 3,163,104 | 6.76% | 13G (passive) | Dec 31, 2025 |
| Wellington Management Group LLP Joint filing with Wellington Group Holdings LLP (5.40%), Wellington Investment Advisors Holdings LLP (5.40%) | 2,688,486 | 5.40% | 13G (passive) amendment | Mar 31, 2025 |
| Vanguard Portfolio Management | 2,600,145 | 5.59% | 13G (passive) | Mar 31, 2026 |
| Vanguard Capital Management | 2,445,817 | 5.26% | 13G (passive) | Mar 31, 2026 |
| North Peak Capital Management, LLC | 2,370,495 | 5.10% | 13G (passive) | Feb 24, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of HAE | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 5,909,258 | 12.99% | $443.19M | +289,279 | 0.01% |
| Neuberger Berman Group LLC | 4,179,443 | 9.19% | $313.47M | +618,525 | 0.21% |
| Vanguard Portfolio Management LLC | 2,546,394 | 5.60% | $190.98M | −12,922 | 0.01% |
| Aqr Capital Management LLC | 2,266,489 | 4.98% | $165.02M | −1,090,054 | 0.06% |
| Ariel Investments, LLC | 2,060,966 | 4.53% | $154.57M | New | 1.54% |
| Vanguard Capital Management LLC | 2,059,578 | 4.53% | $154.47M | −30,811 | 0.00% |
| State Street Corp | 1,818,186 | 4.00% | $136.36M | +45,288 | 0.00% |
| Dimensional Fund Advisors LP | 1,585,222 | 3.48% | $118.89M | +259,165 | 0.02% |
| Citadel Advisors LLC | 1,510,120 | 3.32% | $113.26M | +1,251,967 | 0.01% |
| Geode Capital Management, LLC | 1,287,240 | 2.83% | $96.56M | +68,262 | 0.01% |
| River Road Asset Management, LLC | 1,285,602 | 2.83% | $96.42M | −42,387 | 1.07% |
| Arrowstreet Capital, Limited Partnership | 1,155,351 | 2.54% | $86.65M | −227,653 | 0.04% |
| T. Rowe Price Investment Management, Inc. | 1,101,371 | 2.42% | $82.60M | +504,216 | 0.05% |
| Goldman Sachs Group Inc | 1,046,019 | 2.30% | $78.45M | +93,199 | 0.01% |
| UBS Group AG | 983,378 | 2.16% | $73.75M | +456,761 | 0.01% |
| Fort Washington Investment Advisors Inc /Oh/ | 830,925 | 1.83% | $62.32M | −10,092 | 0.31% |
| Royal Bank of Canada | 780,248 | 1.71% | $58.52M | −77,717 | 0.01% |
| Allspring Global Investments Holdings, LLC | 765,120 | 1.68% | $57.27M | −125,104 | 0.09% |
| Price T Rowe Associates Inc /Md/ | 636,797 | 1.40% | $47.76M | +216,522 | 0.00% |
| Deutsche Bank AG\ | 631,663 | 1.39% | $47.37M | +272,781 | 0.01% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 329 | 50M | 100.0% | 55 / 108 | 121 / 46 | 10M | 8M |
| Q1 2026 | 324 | 48M | 100.0% | 56 / 118 | 110 / 56 | 10M | 9M |
| Q4 2025 | 330 | 52M | 100.0% | 77 / 94 | 130 / 41 | 10M | 10M |
| Q3 2025 | 301 | 52M | 100.0% | 57 / 95 | 119 / 52 | 9M | 12M |
| Q2 2025 | 298 | 55M | 100.0% | 34 / 126 | 103 / 48 | 5M | 4M |
| Q1 2025 | 314 | 54M | 100.0% | 55 / 126 | 103 / 46 | 7M | 9M |
| Q4 2024 | 309 | 57M | 100.0% | 49 / 124 | 90 / 42 | 4M | 3M |
| Q3 2024 | 306 | 56M | 100.0% | 45 / 105 | 113 / 53 | 12M | 6M |
| Q2 2024 | 317 | 56M | 100.0% | 54 / 113 | 107 / 33 | 7M | 3M |
| Q1 2024 | 298 | 52M | 100.0% | 43 / 105 | 114 / 40 | 5M | 4M |
| Q4 2023 | 295 | 51M | 100.0% | 37 / 91 | 118 / 36 | 3M | 2M |
| Q3 2023 | 296 | 51M | 100.0% | 37 / 97 | 123 / 35 | 3M | 3M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
385 funds held HAE in Q2 2026, 44% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of HAE | Value | % of fund | As of |
|---|---|---|---|---|---|
| iShares Core S&P Mid-Cap ETF | 1,588,817 | 3.49% | $119.16M | 0.10% | Jun 30, 2026 |
| Neuberger Genesis Fund | 1,491,533 | 3.28% | $101.14M | 1.38% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 1,441,654 | 3.17% | $108.12M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 1,226,767 | 2.70% | $92.01M | 0.11% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 1,041,356 | 2.29% | $78.10M | 0.04% | Jun 30, 2026 |
| Touchstone Strategic Trust-Touchstone Small Company Fund | 614,824 | 1.35% | $46.11M | 2.68% | Jun 30, 2026 |
| Ariel Fund | 573,665 | 1.26% | $43.02M | 1.49% | Jun 30, 2026 |
| Vanguard Extended Market Index Fund | 533,213 | 1.17% | $39.99M | 0.04% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 515,269 | 1.13% | $44.08M | 0.13% | Jul 31, 2026 |
| Allspring Special Small Cap Value Fund | 432,331 | 0.95% | $32.42M | 1.10% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 410,879 | 0.90% | $30.82M | 0.20% | Jun 30, 2026 |
| Neuberger Intrinsic Value Fund | 364,147 | 0.80% | $24.69M | 1.64% | May 31, 2026 |
| Vanguard Small-Cap Value Index Fund | 330,114 | 0.73% | $24.76M | 0.04% | Jun 30, 2026 |
| Franklin Small Cap Growth Fund | 309,605 | 0.68% | $26.48M | 1.07% | Jul 31, 2026 |
| Vanguard Explorer Fund | 308,872 | 0.68% | $26.42M | 0.12% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Simon, Christopher | President & CEO, Director | 444,704 | 0.98% | May 19, 2026 |
| Farris Maryanne Maunsell | VP, Chief Accounting Officer | 5,828 | 0.01% | Nov 13, 2026 |
| Roy Galvin | EVP, Chief Commercial Officer | 39,805 | 0.09% | Nov 3, 2026 |
| Laurie A. Miller | SVP, Human Resources | 40,987 | 0.09% | Jun 8, 2026 |
| Frank Chan | EVP, Chief Operating Officer | 5,401 | 0.01% | May 19, 2026 |
| James DArecca | EVP, Chief Financial Officer | 54,444 | 0.12% | May 19, 2026 |
| Michelle L. Basil | EVP and General Counsel | 68,829 | 0.15% | May 19, 2026 |
| Mark W. Kroll | Director | 27,295 | 0.06% | Jul 28, 2026 |
| Martin D. Madaus | Director | 2,538 | 0.01% | Jul 28, 2026 |
| Ellen M. Zane | Director | 21,911 | 0.05% | Jul 28, 2026 |
| Claire Pomeroy | Director | 19,410 | 0.04% | Jul 28, 2026 |
| Diane M. Bryant | Director | 9,664 | 0.02% | Jul 28, 2026 |
| Lloyd Emerson Johnson | Director | 15,471 | 0.03% | Jul 28, 2026 |
| Robert E. Abernathy | Director | 27,519 | 0.06% | Jul 28, 2026 |
| Michael J. Coyle | Director | 17,932 | 0.04% | Jul 28, 2026 |
| Charles J. Dockendorff | Director | 25,041 | 0.06% | Jul 25, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Farris Maryanne Maunsell VP, Chief Accounting Officer | Nov 11, 2026 | Sale | −836 | $120.99 | $101.15K | 5,828 |
| Farris Maryanne Maunsell VP, Chief Accounting Officer | Nov 11, 2026 | Tax withholding | −1,724 | $121.10 | $208.78K | 6,664 |
| Farris Maryanne Maunsell VP, Chief Accounting Officer | Nov 11, 2026 | Option exercise | +433 | $70.31 | $30.44K | 8,388 |
| Farris Maryanne Maunsell VP, Chief Accounting Officer | Nov 11, 2026 | Option exercise | +645 | $95.73 | $61.75K | 7,955 |
| Farris Maryanne Maunsell VP, Chief Accounting Officer | Nov 11, 2026 | Option exercise | +1,068 | $89.16 | $95.22K | 7,310 |
| Roy Galvin EVP, Chief Commercial Officer | Oct 30, 2026 | Tax withholding | −146 | $119.65 | $17.47K | 39,805 |
| Ellen M. Zane Director | Jul 24, 2026 | Award | +2,538 | – | – | 21,911 |
| Mark W. Kroll Director | Jul 24, 2026 | Award | +2,538 | – | – | 27,295 |
| Michael J. Coyle Director | Jul 24, 2026 | Award | +2,538 | – | – | 17,932 |
| Martin D. Madaus Director | Jul 24, 2026 | Award | +2,538 | – | – | 2,538 |
| Claire Pomeroy Director | Jul 24, 2026 | Award | +2,538 | – | – | 19,410 |
| Lloyd Emerson Johnson Director | Jul 24, 2026 | Award | +2,538 | – | – | 15,471 |
| Robert E. Abernathy Director | Jul 24, 2026 | Award | +2,538 | – | – | 27,519 |
| Diane M. Bryant Director | Jul 24, 2026 | Award | +2,538 | – | – | 9,664 |
| Laurie A. Miller SVP, Human Resources | Jun 5, 2026 | Tax withholding | −313 | $71.28 | $22.31K | 40,987 |
| Farris Maryanne Maunsell VP, Chief Accounting Officer | Jun 5, 2026 | Tax withholding | −259 | $71.28 | $18.46K | 6,242 |
| James DArecca EVP, Chief Financial Officer | May 15, 2026 | Award | +29,312 | – | – | 54,444 |
| James DArecca EVP, Chief Financial Officer | May 15, 2026 | Tax withholding | −2,505 | $56.29 | $141.01K | 25,132 |
| Roy Galvin EVP, Chief Commercial Officer | May 15, 2026 | Tax withholding | −879 | $56.29 | $49.48K | 12,347 |
| Roy Galvin EVP, Chief Commercial Officer | May 15, 2026 | Award | +27,535 | – | – | 39,882 |
| Farris Maryanne Maunsell VP, Chief Accounting Officer | May 15, 2026 | Tax withholding | −197 | $56.29 | $11.09K | 4,281 |
| Farris Maryanne Maunsell VP, Chief Accounting Officer | May 15, 2026 | Award | +2,220 | – | – | 6,501 |
| Frank Chan EVP, Chief Operating Officer | May 15, 2026 | Tax withholding | −546 | $56.29 | $30.73K | 5,401 |
| Frank Chan EVP, Chief Operating Officer | May 15, 2026 | Award | +27,535 | – | – | 32,936 |
| Laurie A. Miller SVP, Human Resources | May 15, 2026 | Award | +13,323 | – | – | 41,300 |
| Laurie A. Miller SVP, Human Resources | May 15, 2026 | Tax withholding | −948 | $56.29 | $53.36K | 27,977 |
| Michelle L. Basil EVP and General Counsel | May 15, 2026 | Award | +28,424 | – | – | 68,829 |
| Michelle L. Basil EVP and General Counsel | May 15, 2026 | Tax withholding | −2,913 | $56.29 | $163.97K | 40,405 |
| Simon, Christopher President & CEO, Director | May 15, 2026 | Award | +78,344 | – | – | 444,704 |
| Simon, Christopher President & CEO, Director | May 15, 2026 | Tax withholding | −9,681 | $56.29 | $544.94K | 366,360 |
| James DArecca EVP, Chief Financial Officer | May 1, 2026 | Tax withholding | −655 | $59.26 | $38.82K | 27,637 |
| Mark W. Kroll Director | Nov 10, 2025 | Buy | +1,400 | $70.56 | $98.78K | 24,757 |
| Roy Galvin EVP, Chief Commercial Officer | Oct 31, 2025 | Tax withholding | −145 | $50.01 | $7.25K | 12,811 |
| Laurie A. Miller SVP, Human Resources | Sep 17, 2025 | Tax withholding | −238 | $49.95 | $11.89K | 28,925 |
| Mark W. Kroll Director | Jul 24, 2025 | Award | +2,693 | – | – | 23,357 |
| Diane M. Bryant Director | Jul 24, 2025 | Award | +2,693 | – | – | 7,126 |
| Lloyd Emerson Johnson Director | Jul 24, 2025 | Award | +2,693 | – | – | 12,933 |
| Michael J. Coyle Director | Jul 24, 2025 | Award | +2,693 | – | – | 15,394 |
| Claire Pomeroy Director | Jul 24, 2025 | Award | +2,693 | – | – | 16,872 |
| Charles J. Dockendorff Director | Jul 24, 2025 | Award | +2,693 | – | – | 7,126 |
| Robert E. Abernathy Director | Jul 24, 2025 | Award | +2,693 | – | – | 24,981 |
| Ellen M. Zane Director | Jul 24, 2025 | Award | +2,693 | – | – | 19,373 |
| Farris Maryanne Maunsell VP, Chief Accounting Officer | Jun 5, 2025 | Award | +2,662 | – | – | 4,478 |
| Laurie A. Miller SVP, Human Resources | Jun 5, 2025 | Award | +3,195 | – | – | 29,163 |
| James DArecca EVP, Chief Financial Officer | May 30, 2025 | Award | +12,221 | – | – | 34,156 |
| James DArecca EVP, Chief Financial Officer | May 30, 2025 | Tax withholding | −5,864 | $69.38 | $406.84K | 28,292 |
| Laurie A. Miller SVP, Human Resources | May 30, 2025 | Award | +7,777 | – | – | 28,251 |
| Laurie A. Miller SVP, Human Resources | May 30, 2025 | Tax withholding | −2,283 | $69.38 | $158.39K | 25,968 |
| Michelle L. Basil EVP and General Counsel | May 30, 2025 | Tax withholding | −7,469 | $69.38 | $518.20K | 42,252 |
| Michelle L. Basil EVP and General Counsel | May 30, 2025 | Award | +15,554 | – | – | 49,721 |
| Simon, Christopher President & CEO, Director | May 30, 2025 | Award | +66,666 | – | – | 401,778 |
| Simon, Christopher President & CEO, Director | May 30, 2025 | Tax withholding | −26,234 | $69.38 | $1.82M | 375,544 |
| Michelle L. Basil EVP and General Counsel | May 16, 2025 | Award | +6,755 | – | – | 35,233 |
| Roy Galvin EVP, Chief Commercial Officer | May 16, 2025 | Award | +5,689 | – | – | 12,932 |
| Simon, Christopher President & CEO, Director | May 16, 2025 | Award | +21,405 | – | – | 335,112 |
| Farris Maryanne Maunsell VP, Chief Accounting Officer | May 16, 2025 | Award | +800 | – | – | 1,816 |
| James DArecca EVP, Chief Financial Officer | May 16, 2025 | Award | +7,111 | – | – | 21,935 |
| Frank Chan EVP, Chief Operating Officer | May 16, 2025 | Award | +5,689 | – | – | 5,689 |
| Roy Galvin President, Global Plasma & BC | May 16, 2025 | Award | +6,755 | – | – | 13,998 |
| Michelle L. Basil EVP and General Counsel | May 16, 2025 | Award | +5,689 | – | – | 34,167 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Haemonetics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,894 shares on Aug 21, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Josep Llorens Former Officer | Jun 26, 2025 | 18,630 | $1.40M | Jun 26, 2025 | Restricted Stock Vesting |
| Stewart W. Strong Former Officer | Jun 12, 2025 | 708 | $50.59K | Jun 12, 2025 | Option Granted 05/16/2022 |
| Stewart W. Strong Officer | Jun 4, 2025 | 7,705 | $538.58K | Jun 4, 2025 | Restricted Stock Vesting |
| Stewart W. Strong Officer | Jun 2, 2025 | 2,835 | $191.28K | Jun 2, 2025 | Restricted Stock Vesting |
| Josep Llorens Officer | May 19, 2025 | 1,547 | $107.32K | May 19, 2025 | Restricted Stock Vesting |
| Anila Lingamneni Former Officer | Nov 12, 2024 | 6,238 | $565.69K | Nov 11, 2024 | ESPP Purchase |
| Stewart W. Strong Officer | Jul 26, 2024 | 4,312 | $393.04K | Jul 26, 2024 | Restricted Stock Vesting |
| Anila Lingamneni Officer | Jul 12, 2024 | 79 | $7.11K | Jul 12, 2024 | Restricted Stock Vesting |
| Anila Lingamneni Officer | Jul 11, 2024 | 2,136 | $192.24K | Jul 11, 2024 | Restricted Stock Vesting |
| Stewart W. Strong Officer | May 29, 2024 | 8,857 | $775.25K | May 29, 2024 | Restricted Stock Vesting |
| Michelle L. Basil Officer | May 29, 2024 | 12,990 | $1.14M | May 29, 2024 | Restricted Stock Vesting |
| Michelle L. Basil Officer | May 20, 2024 | 1,604 | $152.51K | May 20, 2024 | Restricted Stock Vesting |
| Stewart W. Strong Officer | May 20, 2024 | 686 | $65.25K | May 20, 2024 | Option Granted - 05/18/2021 |
| Josep Llorens Officer | May 20, 2024 | 987 | $93.84K | May 20, 2024 | Restricted Stock Vesting |
| Michelle L. Basil Officer | May 17, 2024 | 1,073 | $101.94K | May 17, 2024 | Restricted Stock Vesting |
Congress trades
13 trades in Haemonetics reported by 3 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Lois Frankel FL22 | Sold | May 7, 2021 | $1K–15K | May 25, 2021 |
| Lois Frankel FL22 | Sold (part) | May 6, 2021 | $1K–15K | May 25, 2021 |
| Josh Gottheimer NJ05 · joint account | Sold | Jan 25, 2021 | $1K–15K | Feb 9, 2021 |
| Josh Gottheimer NJ05 · joint account | Bought | Oct 16, 2020 | $1K–15K | Nov 5, 2020 |
| Josh Gottheimer NJ05 · joint account | Sold (part) | Sep 15, 2020 | $1K–15K | Oct 13, 2020 |
| Lois Frankel FL22 | Bought | Aug 14, 2020 | $1K–15K | Aug 24, 2020 |
| Gilbert Cisneros CA31 | Bought | Jun 1, 2020 | $1K–15K | Jun 16, 2020 |
| Josh Gottheimer NJ05 · joint account | Bought | May 28, 2020 | $1K–15K | Jun 10, 2020 |
| Gilbert Cisneros CA31 | Bought | May 19, 2020 | $1K–15K | Jun 16, 2020 |
| Josh Gottheimer NJ05 · joint account | Bought | May 15, 2020 | $1K–15K | Jun 10, 2020 |
| Lois Frankel FL22 | Sold | Aug 7, 2018 | $1K–15K | Aug 24, 2018 |
| Lois Frankel FL22 | Sold (part) | Jun 14, 2018 | $1K–15K | Jun 22, 2018 |
| Lois Frankel FL22 | Sold (part) | Jun 7, 2018 | $1K–15K | Jun 22, 2018 |
See a number that looks wrong?